Pyoderma gangrenosum: proposed pathogenesis and current use of biologics with an emphasis on complement C5a inhibitor IFX-1-论文-万方医学网

Pyoderma gangrenosum: proposed pathogenesis and current use of biologics with an emphasis on complement C5a inhibitor IFX-1

导出原文传递

翻译打印收藏纠错

作者： Lu, Justin D. ^[1] ; Milakovic, Milica ^[2] ; Ortega-Loayza, Alex G. ^[3] ; Marzano, Angelo V. ^[4] ; Alavi, Afsaneh ^[5]

作者单位： McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada ^[1] Univ Toronto, Fac Med, Toronto, ON, Canada ^[2] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR USA ^[3] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dermatol Unit, Milan, Italy ^[4] Univ Toronto, Dept Med, Div Dermatol, Toronto, ON, Canada ^[5]

关键词 C5a pyoderma gangrenosum IFX-1 clinical trial hidradenitis suppurativa complement neutrophilic dermatoses pathophysiology

发布时间 2022-09-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除